doc. Mgr. Kamil Paruch, Ph.D.
Associate professor, Department of Chemistry
correspondence Address:
Kotlářská 267/2, 611 37 Brno
office: bldg. A08/322
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 5477 |
|---|---|
| e‑mail: |
Total number of publications: 159
2020
-
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe
Molecular oncology, year: 2020, volume: 14, edition: 10, DOI
2019
-
ATR-CHK1 signaling is active and targetable in quiescent CLL cells
Year: 2019, type: Conference abstract
-
CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes
EMBO reports, year: 2019, volume: 20, edition: 9, DOI
-
Cílená inhibice kasein kinázy 1 v léčbě chronické lymfoidní leukémie.
Year: 2019, type: Conference abstract
-
EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology
SLAS DISCOVERY, year: 2019, volume: 24, edition: 3, DOI
-
Furo[3,2-b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway
Angewandte Chemie International Edition, year: 2019, volume: 58, edition: 4, DOI
-
CHK1 INHIBITION FACILITATES THE COOPERATIVE ANTICANCER ACTION OF PLATINUM-BASED DRUGS AND TRAIL
Year: 2019, type: Conference abstract
-
Inhibition of Chk1 enhances cooperative anticancer action of platinum-based drugs and TRAIL via activation of mitochondrial apoptotic pathway
Year: 2019, type: Conference abstract
-
Nanopatterning Glass Surface For Localization Of Embryonic Stem Cells
Year: 2019, type: Conference abstract
-
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells
Haematologica, year: 2019, volume: 104, edition: 12, DOI